Topical glucocorticosteroids in rhinitis: mode of action

References

• Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. BMJ 1973; 4: 464–6.
   PubMed Web of Science ®Google Scholar
• Pipkorn U. Budesonide and nasal histamine challenge. Allergy 1982; 37: 359–63.
   PubMed Web of Science ®Google Scholar
• Pipkorn U, Enerbäck L. Nasal mucosal mast cells and histamine in hay fever: effect of topical glucocorticoid treatment. Int Arch Allergy Appl Immunol 1987; 84: 123–8.
   PubMedGoogle Scholar
• Gomez E, Clague J, Gatland D, Davies R. Effect of topical corticosteroids on seasonally induced increase in nasal mast cells. BMJ 1988; 246: 1572–3.
   Google Scholar
• Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli S, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988; 81: 580–9.
   PubMed Web of Science ®Google Scholar
• Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic corticosteroids. Am Rev Respir Dis 1988; 138: 406–12.
   PubMedGoogle Scholar
• Klementsson H, Svensson C, Andersson M, Venge P, Pipkorn U, Persson CG. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991; 21: 705–10.
   PubMed Web of Science ®Google Scholar
• Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991; 87: 893–910.
   PubMed Web of Science ®Google Scholar
• Rak S, Jacobson MR, Sudderick RM, Masuyama K, Kay AB, Hamid Q, et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994; 24: 930–9.
   PubMed Web of Science ®Google Scholar
• Masuyama K, Rak S, Jacobson MR, Löwhagen O, Hamid Q, Durham SR. Rhinitis at the cellular level. Eur Respir Rev 1994; 4: 252–5.
   Google Scholar
• Kanai N, Denburg JA, Evans S, Conway M, Jordana M, Dolovich J. Nasal polyp inflammation. Effect of topical nasal steroid. Am J Respir Crit Care Med 1994; 150: 1094–100.
   PubMed Web of Science ®Google Scholar
• Cox G, Ohtoshi T, Vancheri C, Denburg J, Dolovich J, Gauldie J, et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991; 4: 525–31.
   PubMed Web of Science ®Google Scholar
• Holt P. Immune tolerance and protection against allergic sensitization. Allergy 1995; 50(Suppl 25): 34–6.
   PubMed Web of Science ®Google Scholar
• Pawankar RU, Okuda M, Hasegawa S, Suzuki K, Yssel H, Okuba K, et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med 1995; 152: 2059–67.
   PubMed Web of Science ®Google Scholar
• Naclerio RM, Adkinson NF Jr, Creticos PS, Baroody FM, Hamilton RG, Norman PS. Intranasal steroids inhibit seasonal increase in ragweed-induced immunoglobulin E antibodies. J Allergy Clin Immunol 1993; 92: 517–21.
   Web of Science ®Google Scholar
• Karlsson MG, Davidsson A, Viale G, Graziani D, Hellquist HB. Nasal messenger RNA expression of interleukins 2, 4 and 5 in patients with allergic rhinitis. Diagn Mol Pathol 1995; 4: 85–92.
   PubMedGoogle Scholar
• Holm AF, Fokkens WJ, Godthelp T, Mulder PGH, Vroom TM, Rijntjes E. Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995; 50: 204–9.
   PubMed Web of Science ®Google Scholar
• Bende M, Lindqvist N, Pipkorn U. The effect of a topical steroid, budesonide, on nasal mucosal blood flow as measured with 133Xe wash-out technique. Allergy 1983; 38: 461–4.
   PubMed Web of Science ®Google Scholar
• Persson CGA, Erjefält JS, Andersson M, Greiff L, Svensson C. Microvascular-epithelial exudation of bulk plasma in airway defence, disease, and repair. In: Holgate ST, Busse WW, editors. Inflammatory mechanisms in asthma. New York: Marcel Dekker; 1998. p. 599–617.
   Google Scholar
• Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical gluco-corticos- teroids. N Engl J Med 1987; 316: 1506–10.
   PubMed Web of Science ®Google Scholar
• Svensson C, Klementsson H, Andersson M, Pipkorn U, Alkner U, Persson CGA. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis. Allergy 1994; 49: 177–83.
   PubMed Web of Science ®Google Scholar
• Andersson M, Andersson P, Pipkorn U. Topical glucocorticosteroids and allergen-induced increase in nasal reactivity. Relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 1988; 82: 1019–26.
   PubMed Web of Science ®Google Scholar
• Andersson M, Andersson P, Pipkorn U. Allergen-induced specific and non-specific nasal hyperreactivity. Reciprocal relationship and inhibition by topical glucocorticosteroids. Acta Otolaryngol (Stockh) 1989; 107: 270–7.
   PubMed Web of Science ®Google Scholar